ANEMIA ASSESSMENT IN IRAQI PATIENTS WITH TYPE II DIABETES: A CASE-CONTROL INVESTIGATION

Abstract

Introduction: Diabetes mellitus encompasses a diverse range of chronic conditions marked by increased levels of blood sugar. When an individual with diabetes also experiences anemia, it can substantially impact their quality of life and is related to the worsening of their condition. Method: The study involved an overall of 80 samples, which were divided into two groups: one including patients and the other serving as controls. Definitely, the patient group involved 40 individuals identified with diabetes, while the control group involved of healthy individuals aged between 30 and 58 years. Results: The results indicated that glycated haemoglobin (HbA1C) levels in patients were significantly advanced (p< 0.01) than in controls. The results also exposed a significant increase in fasting blood sugar (FBS) in Type II Diabetes patients as related to the control evaluations. Conclusion: In conclusion, as related to the general population, anemia is a recurrent remark among Type II Diabetes patients. On this evidence, we propose that routine hematological testing, as well as blood glucose levels, be made necessary in diabetic outpatient clinics in order to mark the best therapeutic approvals for treating anemia in type II diabetes mellitus.